EYEPOINT PHARMACEUTICALS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.34 EUR | +2.38% |
|
-1.96% | -50.54% |
| May. 08 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
| May. 08 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
Quotes 5-day view
Delayed Quote Deutsche Boerse AG| 2024-05-21 | 2024-05-22 | 2024-05-23 | 2024-05-24 | 2024-05-27 | |
|---|---|---|---|---|---|
| Last | 10.89 € | 10.5 € | 10.52 € | 10.1 € | 10.48 € |
| Change | +1.82% | -3.58% | +0.19% | -3.99% | +2.38% |
Performance
| 1 day | +2.38% | ||
| 1 week | -1.96% | ||
| Current month | -45.23% | ||
| 1 month | -42.66% | ||
| 3 months | -57.03% | ||
| 6 months | +90.64% | ||
| Current year | -50.54% | ||
| 1 year | +90.64% | ||
| 3 years | +35.29% | ||
| 5 years | -26.93% | ||
| 10 years | -60.86% |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
581 261 625
Capitalization (USD)
581 261 625
Net sales (USD)
46 018 000
Number of employees
121
Sales / Employee (USD)
380 314
Free-Float
97.47 %
Free-Float capitalization (EUR)
615 160 449
Free-Float capitalization (USD)
566 534 476
Average Daily Capital Traded
0%
Highs and lows
1 week
10.10
11.02
1 month
10.1018.46
Current year
10.1028.60
1 year
5.2528.60
3 years
2.0828.60
5 years
0.3828.60
10 years
0.3850.00
Indicators
Moving average 5 days
10.54
Moving average 20 days
14.50
Moving average 50 days
18.38
Moving average 100 days
20.36
Price spread / (MMA5)
+1.94%
Price spread / (MMA20)
+40.21%
Price spread / (MMA50)
+77.76%
Price spread / (MMA100)
+96.86%
STIM
RSI 9 days
24.86
RSI 14 days
27.40
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +2.38% | -1.96% | -50.54% | +90.64% | 581M | ||
| -0.13% | +4.86% | +38.51% | +89.63% | 727B | ||
| -0.98% | -0.81% | +31.74% | +64.82% | 599B | ||
| -1.82% | -4.96% | -6.23% | -4.78% | 354B | ||
| -1.22% | -1.30% | +18.78% | +16.58% | 328B | ||
| -0.76% | -5.62% | +1.35% | +14.18% | 277B | ||
| -0.87% | +1.54% | +16.00% | +4.34% | 243B | ||
| +0.32% | -1.98% | +8.44% | +5.76% | 205B | ||
| -0.22% | -1.92% | -5.97% | -20.15% | 203B | ||
| -0.22% | -2.12% | +6.19% | +40.99% | 164B | ||
| +0.66% | +0.84% | +0.31% | -23.19% | 164B | ||
| +0.38% | +0.79% | +0.11% | -9.19% | 121B | ||
| -0.20% | -0.03% | +22.36% | +27.46% | 92.24B | ||
| -0.72% | -6.34% | -19.63% | -35.38% | 83.6B | ||
| -0.74% | -3.01% | -18.92% | -14.80% | 81.83B | ||
| +3.36% | +1.74% | +45.33% | +24.85% | 66.5B | ||
| Average | -0.05% | -1.27% | +5.49% | +16.98% | ||
| Weighted average by Cap. | -0.52% | -0.03% | +15.82% | +30.11% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
90c2e6700.SEs0tIoi3DJfQE9500U-7t6zQ4G3Hf8_0rI7k_dpsb0.fnwF3chJvmMYeD4K5nxqoenmddCDTYlnoONC0Ycm8O0aE17ZvROxcxx2Bg
| Date | Price | Volume | Daily volume |
|---|
Monthly variations
Annual change
| 2024 | -52.36% | ||
| 2023 | +558.39% | ||
| 2022 | -70.99% | ||
| 2021 | +151.70% | ||
| 2020 | -66.59% | ||
| 2019 | -12.00% | ||
| 2018 | +73.81% | ||
| 2017 | -45.03% | ||
| 2016 | -64.99% | ||
| 2015 | +31.60% | ||
| 2014 | +19.70% | ||
| 2013 | +195.95% | ||
| 2012 | +14.12% | ||
| 2011 | -77.16% | ||
| 2010 | +38.24% | ||
| 2009 | +316.54% | ||
| 2008 | -72.13% |
- Stock Market
- Equities
- EYPT Stock
- PV3B Stock
- Quotes EyePoint Pharmaceuticals, Inc.
